These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1454349)

  • 1. Effect of mydriasis on visual field area in retinitis pigmentosa.
    Lam BL; Fishman GA; Anderson RJ; Smith DA; Alexander KR
    Ophthalmology; 1992 Nov; 99(11):1724-7. PubMed ID: 1454349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of visual field loss in retinitis pigmentosa.
    Grover S; Fishman GA; Anderson RJ; Alexander KR; Derlacki DJ
    Ophthalmology; 1997 Mar; 104(3):460-5. PubMed ID: 9082273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual acuity and visual field impairment in Usher syndrome.
    Edwards A; Fishman GA; Anderson RJ; Grover S; Derlacki DJ
    Arch Ophthalmol; 1998 Feb; 116(2):165-8. PubMed ID: 9488267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mydriasis and miosis on kinetic perimetry findings in normal participants.
    Hirasawa K; Shoji N; Kobashi C; Yamanashi A
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1341-6. PubMed ID: 25981119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the Visual Field Loss in Retinitis Pigmentosa Using Semi-Automated Kinetic Perimetry.
    Nowomiejska K; Brzozowska A; Koss MJ; Weleber RG; Schiefer U; Rejdak K; Juenemann AG; Maciejewski R; Rejdak R
    Curr Eye Res; 2016 Jul; 41(7):993-8. PubMed ID: 26470834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability and Errors of Manually Digitized Goldmann Visual Fields.
    Barry MP; Bittner AK; Yang L; Marcus R; Iftikhar MH; Dagnelie G
    Optom Vis Sci; 2016 Jul; 93(7):720-30. PubMed ID: 27058594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa.
    Iannaccone A; Rispoli E; Vingolo EM; Onori P; Steindl K; Rispoli D; Pannarale MR
    Doc Ophthalmol; 1995; 90(2):129-42. PubMed ID: 7497885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa.
    Bittner AK; Seger K
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):299-306. PubMed ID: 29222719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in isopter position and fatigue during semi-automated kinetic perimetry.
    Nowomiejska K; Brzozowska A; Zarnowski T; Rejdak R; Weleber RG; Schiefer U
    Ophthalmologica; 2012; 227(3):166-72. PubMed ID: 22205248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A dissociation of thresholds between Goldmann kinetic perimetry and high-pass resolution perimetry in retinitis pigmentosa].
    Tokuhisa T; Oyama K; Tamaki R; Kitahara K
    Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1429-32. PubMed ID: 1476073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular carbon dioxide reactivity in retinitis pigmentosa. Perimetry results].
    Tacke CM; Pillunat LE; Lang GK
    Ophthalmologe; 1993 Oct; 90(5):510-4. PubMed ID: 8219642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa.
    Bittner AK; Iftikhar MH; Dagnelie G
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8042-6. PubMed ID: 21896857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal isopter position in the peripheral visual field in goldmann kinetic perimetry.
    Niederhauser S; Mojon DS
    Ophthalmologica; 2002; 216(6):406-8. PubMed ID: 12566882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual acuity loss in retinitis pigmentosa. Relationship to visual field loss.
    Madreperla SA; Palmer RW; Massof RW; Finkelstein D
    Arch Ophthalmol; 1990 Mar; 108(3):358-61. PubMed ID: 2310334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Central Retinal Artery Blood Flow Is Related to Impaired Central Visual Function in Retinitis Pigmentosa Patients.
    Kayser S; Vargas P; Mendelsohn D; Han J; Bi H; Benavente A; Bittner AK
    Curr Eye Res; 2017 Nov; 42(11):1503-1510. PubMed ID: 28910168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.
    Bhalla S; Joshi D; Bhullar S; Kasuga D; Park Y; Kay CN
    Br J Ophthalmol; 2013 Jul; 97(7):895-9. PubMed ID: 23603755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery dynamics of multifocal pupillographic objective perimetry from tropicamide dilation.
    Rai BB; Sabeti F; Carle CF; Rohan EMF; Saraç Ö; van Kleef J; Maddess T
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):191-200. PubMed ID: 31720837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wide-field fundus autofluorescence imaging of retinitis pigmentosa.
    Oishi A; Ogino K; Makiyama Y; Nakagawa S; Kurimoto M; Yoshimura N
    Ophthalmology; 2013 Sep; 120(9):1827-34. PubMed ID: 23631947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.